<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>28711461</identifier>
<setSpec>1885-1398</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Gamero, Fernando</dc:author>
<dc:author>Gómez-Centeno, Antonio</dc:author>
<dc:author>Fernández-Nebro, Antonio</dc:author>
<dc:author>Bermúdez, Alberto</dc:author>
<dc:author>Rosas, José</dc:author>
<dc:author>Ruiz-Esquide, Virginia</dc:author>
<dc:author>Corrales, Alfonso</dc:author>
<dc:author>Marras, Carlos</dc:author>
<dc:author>Narváez, Javier</dc:author>
<dc:author>Hmamouchi, Ihsane</dc:author>
<dc:author>Balsa, Alejandro</dc:author>
<dc:author>García-Manrique, María</dc:author>
<dc:author>Cáliz, Rafael</dc:author>
<dc:author>Lojo-Oliveira, Leticia</dc:author>
<dc:author>Campos, José</dc:author>
<dc:author>Muñoz-Fernández, Santiago</dc:author>
<dc:author>Martín-Mola, Emilio</dc:author>
<dc:author>García-Vicuña, Rosario</dc:author>
<dc:author>Ojeda, Soledad</dc:author>
<dc:author>Rodríguez-Rodríguez, Luis</dc:author>
<dc:author>Hernández-Cruz, Blanca</dc:author>
<dc:author>García-Torrón, José</dc:author>
<dc:author>Sanmartí, Raimon</dc:author>
<dc:author>Ordóñez-Cañizares, Carmen</dc:author>
<dc:author>Pérez, Lorena</dc:author>
<dc:author>García-Llorente, José Francisco</dc:author>
<dc:author>Abasolo-Alcázar, Lydia</dc:author>
<dc:author>Nolla, Joan M</dc:author>
<dc:author>Rey-Rey, José</dc:author>
<dc:author>Rodríguez-Lozano, Carlos</dc:author>
<dc:author>Alperi-López, Mercedes</dc:author>
<dc:author>González-Gay, Miguel Ángel</dc:author>
<dc:description xml:lang="en">OBJECTIVES To describe the prevalence of comorbidities in patients with RA in Spain and discuss their management and implications using data from the Spanish cohort of the multinational study on COMOrbidities in Rheumatoid Arthritis (COMORA). METHODS This is a national sub-analysis of the COMORA study. We studied the demographics and disease characteristics of 200 adults patients diagnosed with RA (1987 ACR), and routine practices for screening and preventing the following selected comorbidities: cardiovascular, infections, cancer, gastrointestinal, pulmonary, osteoporosis and depression. RESULTS Patients had a mean age of 58 years and a mean RA duration of 10 years. Mean DAS28 score was 3.3 and approximately 25% of patients were in remission (DAS28 &lt;2.6). Forty-four (22%) patients had ≥1 comorbidity, the most frequent being depression (27%) and obesity (26%). A history of myocardial infarction or stroke was observed in 5% and 1% of patients, respectively, and any solid tumor in 6%. Having a Framingham Risk Score &gt;20% (51%), hypercholesterolemia (46%) or hypertension (41%) and smoking (25%) were the most common CV risk factors. For prostate, colon and skin cancers, only 9%, 10% and 18% of patients, respectively, were optimally monitored. Infections were also inadequately managed, with 7% and 17% of patients vaccinated against influenza and pneumococcal, respectively, as was osteoporosis, with 47% of patients supplemented with vitamin D and 56% with a bone densitometry performed. CONCLUSIONS In Spain, the prevalence of comorbidities and CV risk factors in RA patients with established and advanced disease is relatively high, and their management in clinical daily practice remains suboptimal.</dc:description>
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:subject>Artritis reumatoide</dc:subject>
<dc:subject>Prevalence</dc:subject>
<dc:subject>Comorbidities</dc:subject>
<dc:subject>Prevalencia</dc:subject>
<dc:subject>Rheumatoid arthritis</dc:subject>
<dc:subject>Comorbilidades</dc:subject>
<dc:subject>Factores de riesgo</dc:subject>
<dc:subject>Risk factors</dc:subject>
<dc:date>2017 Jul 12 </dc:date>
<dc:title xml:lang="en">Prevalence of Comorbidities in Rheumatoid Arthritis and Evaluation of Their Monitoring in Clinical Practice: The Spanish Cohort of the COMORA Study.</dc:title>
<dc:publisher>Reumatologia clinica</dc:publisher>
</metadata>
</record>
</pubmed-document>
